News & Perspective

Jan 23, 2013

Jan 23, 2013

Research moratorium on modified H5N1 viruses ends

(CIDRAP News) – A year-long voluntary moratorium on research involving transmissible H5N1 avian flu viruses ended today with a letter from a group of scientists that supports resuming the work in countries that have addressed the biosafety issues involved.

Dec 18, 2012

Dec 18, 2012

Experts at NIH meeting say H5N1 research moratorium may end soon

(CIDRAP News) – As a meeting to discuss issues related to federally funded H5N1 avian influenza research wrapped up today, experts anticipated that a voluntary moratorium on work with lab-modified strains that have increased transmissibility might end soon and said they sensed agreement about lab biosecurity levels.

Jun 21, 2012

Jun 21, 2012

Fouchier study reveals changes enabling airborne spread of H5N1

(CIDRAP News) – A study showing that it takes as few as five mutations to turn the H5N1 avian influenza virus into an airborne spreader in mammals—and that launched a historic debate on scientific accountability and transparency—was released today in Science, spilling the full experimental details that many experts had sought to suppress out of concern that publishing them could lead to the unleashing of a dangerous virus.

Apr 28, 2011

Apr 28, 2011

Federal preparedness advisers approve disaster research recommendations

(CIDRAP News) – A federal advisory board meeting in Washington, DC, today approved a set of recommendations that would help mobilize the scientific response in the wake of major public health events such as the 2009 H1N1 pandemic and the Deepwater Horizon oil spill.

Aug 19, 2010

Aug 19, 2010

HHS sees greater federal role in building biodefense tools

(CIDRAP News) – Federal health officials, in releasing today a blueprint for overhauling the nation's civilian biodefense program, called for increased government partnerships with the private sector and a number of innovative steps to boost the development of medical countermeasures (MCMs) that have little or no commercial market.

Aug 19, 2010

Obama's science advisors outline plan for faster pandemic vaccine

(CIDRAP News) – In light of vaccine production problems that delayed the delivery of the pandemic H1N1 vaccine, a report by President Barack Obama's science advisers released today said targeted investments in five specific areas could trim the time needed to quickly produce enough to protect the nation by weeks or months.

Feb 09, 2010

Feb 09, 2010

Major review of biodefense measures to start soon

(CIDRAP News) – A comprehensive review of the nation's tools for reducing the impact of a biological weapons attack or other public health emergency—prompted in part by last fall's delays in delivery of the pandemic H1N1 vaccine—is due to get under way in the next few weeks with a pair of conferences.

Sep 09, 2008

Sep 09, 2008

HHS funds work on new anthrax antitoxin

(CIDRAP News) – Emergent BioSolutions Inc. recently announced that it won a federal contract worth $24.3 million to develop a monoclonal antibody treatment to block the effects of anthrax toxin.

Feb 04, 2008

Feb 04, 2008

HHS budget proposal cuts state preparedness, boosts food safety

(CIDRAP News) – The Bush administration today unveiled a $3.1 trillion budget for the 2009 fiscal year that cuts a number of public health initiatives but includes an increase for the Food and Drug Adminstration's (FDA's) food safety efforts.

Oct 16, 2007

Oct 16, 2007

US funds work on drugs for plague, tularemia, anthrax

(CIDRAP News) – The US government recently awarded contracts totaling about $34 million to two companies for development of drugs to treat pneumonic plague, tularemia, and anthrax, three of the diseases terrorists are deemed most likely to try to exploit.

Pages

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation Unorthodox Philanthropy logo and text 'Leading Underwriter'3M logoGilead 
Grant support for ASP provided by


bioMérieux

  Become an underwriter»